Expression of RPS3A in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS3A is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 4007.68

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3231.1

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	11004.3
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	9658.5
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	8320.3
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	8114.1
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	8036.5
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	7950.4
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	6904.5
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	6811.4
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	6781.7
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	6172.8
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	6167.5
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	5880.6
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	5856.8
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	5549.7
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	5515.3
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	5428.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	5428.0
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	5387.7
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	5215.9
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	5181.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	5125.8
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	4714.4
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	4545.5
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	4531.2
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	4511.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	4374.3
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	4308.5
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	4241.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	4135.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	4058.2
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	4038.4
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	4008.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	4006.5
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	3979.4
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	3949.3
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3937.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	3898.9
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	3853.9
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	3629.4
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	3628.7
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	3545.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	3447.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3430.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3388.3
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3370.0
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	3321.5
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3311.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3300.9
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	3265.6
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	3265.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	3247.8
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3242.2
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3220.4
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3200.2
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	3176.4
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	3160.5
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3144.2
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	3021.8
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3021.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3010.3
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3010.1
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2909.3
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2899.8
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	2891.2
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2876.7
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2817.8
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	2797.3
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	2788.6
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2781.2
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	2765.5
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2742.0
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	2712.5
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2687.4
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2670.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	2653.6
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2646.5
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2613.2
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2561.6
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2535.9
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2511.0
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2494.1
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	2438.4
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2392.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	2387.3
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2377.8
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2375.3
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2346.6
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	2322.0
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2297.2
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	2292.6
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2275.5
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2266.5
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2259.2
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2249.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	2228.6
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	2217.9
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2202.8
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2200.9
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2091.5
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2080.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	2075.0
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2068.5
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2065.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2050.5
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	2044.2
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2038.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	2026.5
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1976.2
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1975.5
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1947.5
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1936.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1933.5
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1918.9
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1904.1
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1855.7
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1848.4
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1820.1
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1813.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1809.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1791.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1766.2
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1762.0
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1760.7
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1749.2
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1701.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1674.2
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1650.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1648.2
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1621.9
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1594.8
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1585.0
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1578.4
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1552.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1482.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1480.3
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1431.5
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1402.7
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1321.3
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1187.2
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1091.3
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1048.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPS3A is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1289.15

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1106.9

Number of samples

Samples

Sample	Description	pTPM
AK066	N, NA, stage:NA, alive, 960 days	2589.1
AK049	N, NA, stage:NA, dead, 180 days	1948.2
AK156	N, NA, stage:NA, dead, 330 days	1945.7
AK133	N, NA, stage:NA, dead, 360 days	1896.1
AK139	N, NA, stage:NA, dead, 270 days	1866.8
AK124	N, NA, stage:NA, alive, 1920 days	1777.6
AK165	N, NA, stage:NA, alive, 360 days	1682.6
AK183	N, NA, stage:NA, alive, 360 days	1587.7
AK002	N, NA, stage:NA, dead, 570 days	1579.1
AK195	N, NA, stage:NA, dead, 390 days	1522.7
AK074	N, NA, stage:NA, alive, 300 days	1512.5
AK142	N, NA, stage:NA, alive, 90 days	1502.5
AK098	N, NA, stage:NA, dead, 660 days	1426.3
AK231	N, NA, stage:NA, dead, 240 days	1405.0
AK051	N, NA, stage:NA, dead, 360 days	1374.2
AK199	N, NA, stage:NA, alive, 1860 days	1368.1
AK236	N, NA, stage:NA, dead, 360 days	1337.0
AK185	N, NA, stage:NA, alive, 330 days	1331.2
AK072	N, NA, stage:NA, dead, 150 days	1247.1
AK205	N, NA, stage:NA, dead, 120 days	1237.2
AK178	N, NA, stage:NA, dead, 240 days	1180.3
AK055	N, NA, stage:NA, dead, 240 days	1150.9
AK173	N, NA, stage:NA, dead, 180 days	1149.9
AK043	N, NA, stage:NA, alive, 660 days	1131.5
AK188	N, NA, stage:NA, alive, 420 days	1092.4
AK030	N, NA, stage:NA, dead, 120 days	1063.3
AK003	N, NA, stage:NA, dead, 600 days	1044.8
AK071	N, NA, stage:NA, dead, 540 days	1042.0
AK216	N, NA, stage:NA, dead, 360 days	1026.4
AK015	N, NA, stage:NA, alive, 720 days	1025.6
AK041	N, NA, stage:NA, alive, 810 days	972.2
AK053	N, NA, stage:NA, dead, 300 days	970.8
AK213	N, NA, stage:NA, alive, 2010 days	958.7
AK149	N, NA, stage:NA, dead, 420 days	925.1
AK158	N, NA, stage:NA, dead, 360 days	919.8
AK153	N, NA, stage:NA, dead, 240 days	896.4
AK081	N, NA, stage:NA, dead, 180 days	888.0
AK088	N, NA, stage:NA, dead, 360 days	883.1
AK100	N, NA, stage:NA, alive, 960 days	870.6
AK123	N, NA, stage:NA, dead, 180 days	851.1
AK227	N, NA, stage:NA, alive, 300 days	843.8
AK089	N, NA, stage:NA, dead, 330 days	820.4
AK076	N, NA, stage:NA, alive, 660 days	818.1
AK167	N, NA, stage:NA, dead, 180 days	806.4
AK091	N, NA, stage:NA, dead, 210 days	796.6
AK134	N, NA, stage:NA, dead, 360 days	776.6
AK079	N, NA, stage:NA, dead, 210 days	736.2
AK103	N, NA, stage:NA, alive, 1320 days	735.6
AK068	N, NA, stage:NA, alive, 360 days	704.7
AK102	N, NA, stage:NA, alive, 1740 days	661.8
AK099	N, NA, stage:NA, dead, 420 days	651.3
AK006	N, NA, stage:NA, dead, 360 days	598.3
AK005	N, NA, stage:NA, dead, 240 days	584.1
AK035	N, NA, stage:NA, dead, 210 days	569.1
AK226	N, NA, stage:NA, dead, 360 days	564.9
AK218	N, NA, stage:NA, dead, 180 days	531.9
AK117	N, NA, stage:NA, dead, 210 days	524.3
AK085	N, NA, stage:NA, alive, 660 days	296.6
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0127480003	Tumor	0.6
CPT0206560003	Tumor	0.6
CPT0218690004	Tumor	0.6
CPT0219080004	Tumor	0.5
CPT0217710008	Tumor	0.4
CPT0206230003	Tumor	0.4
CPT0217000004	Tumor	0.4
CPT0182580003	Tumor	0.4
CPT0093590003	Tumor	0.4
CPT0224390004	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0206000004	Tumor	0.3
CPT0078580003	Tumor	0.3
CPT0217430008	Tumor	0.3
CPT0168380003	Tumor	0.3
CPT0168080003	Tumor	0.3
CPT0190360004	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0189460003	Tumor	0.3
CPT0205450004	Tumor	0.2
CPT0162020003	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0093450003	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0125510003	Tumor	0.2
CPT0093510003	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0206880003	Tumor	0.2
CPT0162100003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0168480003	Tumor	0.1
CPT0071100003	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0168590003	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0208980003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0206110003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0207090003	Tumor	0.0
CPT0161730003	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0186100003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0125220003	Tumor	0.0
CPT0218330004	Tumor	0.0
CPT0171580008	Tumor	0.0
CPT0204330003	Normal	0.0
CPT0217880003	Tumor	0.0
CPT0175060003	Tumor	0.0
CPT0206780003	Tumor	0.0
CPT0167640003	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0204340003	Normal	0.0
CPT0221180003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0167970003	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0204370003	Normal	-0.1
CPT0168270003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0205890003	Tumor	-0.1
CPT0196850003	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0089150003	Tumor	-0.2
CPT0209440003	Tumor	-0.2
CPT0204400003	Normal	-0.2
CPT0218890004	Tumor	-0.2
CPT0206330003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0207030003	Tumor	-0.2
CPT0204420003	Normal	-0.2
CPT0204410003	Normal	-0.3
CPT0199770003	Tumor	-0.3
CPT0204380003	Normal	-0.3
CPT0204390003	Normal	-0.3
CPT0204350003	Normal	-0.3
CPT0224330003	Tumor	-0.3
CPT0217190003	Tumor	-0.3
CPT0190240004	Tumor	-0.4
CPT0162140003	Tumor	-0.4
CPT0218770003	Tumor	-0.4
CPT0104330003	Tumor	-0.4
CPT0189250003	Tumor	-0.5
CPT0104220003	Tumor	-0.5
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA047100
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade